1. Home
  2. HLMN vs NVAX Comparison

HLMN vs NVAX Comparison

Compare HLMN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLMN
  • NVAX
  • Stock Information
  • Founded
  • HLMN 1964
  • NVAX 1987
  • Country
  • HLMN United States
  • NVAX United States
  • Employees
  • HLMN N/A
  • NVAX N/A
  • Industry
  • HLMN Industrial Machinery/Components
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HLMN Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • HLMN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • HLMN 1.6B
  • NVAX 1.3B
  • IPO Year
  • HLMN N/A
  • NVAX 1995
  • Fundamental
  • Price
  • HLMN $7.53
  • NVAX $6.60
  • Analyst Decision
  • HLMN Buy
  • NVAX Buy
  • Analyst Count
  • HLMN 5
  • NVAX 5
  • Target Price
  • HLMN $11.25
  • NVAX $16.60
  • AVG Volume (30 Days)
  • HLMN 1.3M
  • NVAX 5.5M
  • Earning Date
  • HLMN 08-05-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • HLMN N/A
  • NVAX N/A
  • EPS Growth
  • HLMN N/A
  • NVAX N/A
  • EPS
  • HLMN 0.09
  • NVAX 2.97
  • Revenue
  • HLMN $1,481,633,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • HLMN $6.41
  • NVAX $56.85
  • Revenue Next Year
  • HLMN $6.57
  • NVAX N/A
  • P/E Ratio
  • HLMN $80.21
  • NVAX $2.22
  • Revenue Growth
  • HLMN 0.31
  • NVAX 25.92
  • 52 Week Low
  • HLMN $6.55
  • NVAX $5.01
  • 52 Week High
  • HLMN $12.08
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • HLMN 49.52
  • NVAX 42.34
  • Support Level
  • HLMN $6.75
  • NVAX $6.26
  • Resistance Level
  • HLMN $7.31
  • NVAX $6.60
  • Average True Range (ATR)
  • HLMN 0.22
  • NVAX 0.27
  • MACD
  • HLMN 0.05
  • NVAX -0.06
  • Stochastic Oscillator
  • HLMN 60.56
  • NVAX 15.94

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: